HQL · abrdn Life Sciences Investors Shares of Beneficial Interest
View on chartInsiders & Stakes
| Saba Capital Management, L.P. 10% Owner | ▼ Sell | Open Market | 2,837,633 Shares held | 9/22/2025 | View profile |
| Daniel R. Omstead President | ▲ Buy | Open Market | 197,518 Shares held | 9/25/2023 | View profile |
| Christian Pittard Director | ▲ Buy | Open Market | 7,923 Shares held | 12/16/2025 | View profile |
| Bill Maher Director | ▲ Buy | Open Market | 1,715 Shares held | 8/23/2024 | View profile |
| Kathleen Goetz Director | ▲ Buy | Open Market | 1,085 Shares held | 4/9/2024 | View profile |
| Todd Reit Director | ▲ Buy | Open Market | 1,000 Shares held | 1/2/2024 | View profile |
| Rose DiMartino Director | ▲ Buy | Open Market | 1,000 Shares held | 7/16/2024 | View profile |
| Chris LaVictoire Mahai Director | ▲ Buy | Open Market | 527 Shares held | 7/16/2026 | View profile |
Transaction History
| Chris LaVictoire Mahai | ▲ Buy | Open Market | 527 | $10K | 7/16/2026 |
| Christian Pittard | ▲ Buy | Open Market | 7,923 | $134K | 12/16/2025 |
| Saba Capital Management, L.P. | ▼ Sell | Open Market | 41,623 | $589K | 9/22/2025 |
| Saba Capital Management, L.P. | ▼ Sell | Open Market | 6,989 | $99K | 9/19/2025 |
| Saba Capital Management, L.P. | ▼ Sell | Open Market | 40,208 | $566K | 9/18/2025 |
| Saba Capital Management, L.P. | ▼ Sell | Open Market | 24,328 | $340K | 9/17/2025 |
| Saba Capital Management, L.P. | ▼ Sell | Open Market | 2,026 | $28K | 9/16/2025 |
| Saba Capital Management, L.P. | ▼ Sell | Open Market | 700 | $10K | 9/15/2025 |
| Saba Capital Management, L.P. | ▼ Sell | Open Market | 15,116 | $216K | 9/11/2025 |
| Saba Capital Management, L.P. | ▼ Sell | Open Market | 14,083 | $198K | 9/2/2025 |
| Saba Capital Management, L.P. | ▼ Sell | Open Market | 23,723 | $330K | 8/29/2025 |
| Saba Capital Management, L.P. | ▼ Sell | Open Market | 400 | $6K | 8/26/2025 |
| Saba Capital Management, L.P. | ▼ Sell | Open Market | 10,710 | $151K | 8/21/2025 |
| Saba Capital Management, L.P. | ▼ Sell | Open Market | 11,419 | $145K | 5/20/2025 |
| Saba Capital Management, L.P. | ▼ Sell | Open Market | 23,729 | $287K | 5/15/2025 |
| Saba Capital Management, L.P. | ▼ Sell | Open Market | 600 | $7K | 5/14/2025 |
| Saba Capital Management, L.P. | ▼ Sell | Open Market | 730 | $9K | 5/13/2025 |
| Saba Capital Management, L.P. | ▼ Sell | Open Market | 12,689 | $152K | 5/8/2025 |
| Saba Capital Management, L.P. | ▼ Sell | Open Market | 1,366 | $17K | 5/7/2025 |
| Saba Capital Management, L.P. | ▼ Sell | Open Market | 9,144 | $108K | 4/17/2025 |
| Saba Capital Management, L.P. | ▼ Sell | Open Market | 1,700 | $20K | 4/15/2025 |
| Saba Capital Management, L.P. | ▼ Sell | Open Market | 15,400 | $180K | 4/14/2025 |
| Saba Capital Management, L.P. | ▼ Sell | Open Market | 30,156 | $336K | 4/10/2025 |
| Saba Capital Management, L.P. | ▼ Sell | Open Market | 6,889 | $80K | 4/4/2025 |
| Saba Capital Management, L.P. | ▼ Sell | Open Market | 10,321 | $126K | 4/3/2025 |
| Saba Capital Management, L.P. | ▼ Sell | Open Market | 29,102 | $357K | 4/2/2025 |
| Saba Capital Management, L.P. | ▼ Sell | Open Market | 17,621 | $219K | 4/1/2025 |
| Saba Capital Management, L.P. | ▼ Sell | Open Market | 48,623 | $612K | 3/31/2025 |
| Saba Capital Management, L.P. | ▼ Sell | Open Market | 3,602 | $47K | 3/28/2025 |
| Saba Capital Management, L.P. | ▼ Sell | Open Market | 32,922 | $428K | 3/27/2025 |
| Saba Capital Management, L.P. | ▼ Sell | Open Market | 2,329 | $31K | 3/24/2025 |
| Saba Capital Management, L.P. | ▼ Sell | Open Market | 200 | $3K | 2/26/2025 |
| Saba Capital Management, L.P. | ▼ Sell | Open Market | 100 | $1K | 2/13/2025 |
| Saba Capital Management, L.P. | ▼ Sell | Open Market | 36,536 | $502K | 2/12/2025 |
| Saba Capital Management, L.P. | ▼ Sell | Open Market | 19,756 | $272K | 2/11/2025 |
| Saba Capital Management, L.P. | ▼ Sell | Open Market | 42,987 | $600K | 2/10/2025 |
| Saba Capital Management, L.P. | ▼ Sell | Open Market | 4,065 | $57K | 2/4/2025 |
| Saba Capital Management, L.P. | ▼ Sell | Open Market | 1,846 | $26K | 2/3/2025 |
| Saba Capital Management, L.P. | ▼ Sell | Open Market | 15,143 | $216K | 1/31/2025 |
| Saba Capital Management, L.P. | ▼ Sell | Open Market | 21,835 | $309K | 1/30/2025 |
| Saba Capital Management, L.P. | ▼ Sell | Open Market | 11,674 | $165K | 1/29/2025 |
| Bill Maher | ▲ Buy | Open Market | 650 | $10K | 8/23/2024 |
| Rose DiMartino | ▲ Buy | Open Market | 1,000 | $16K | 7/16/2024 |
| Saba Capital Management, L.P. | ▲ Buy | Open Market | 100 | $1K | 6/26/2024 |
| Saba Capital Management, L.P. | ▲ Buy | Open Market | 13,812 | $194K | 6/24/2024 |
| Saba Capital Management, L.P. | ▲ Buy | Open Market | 8,467 | $117K | 6/13/2024 |
| Saba Capital Management, L.P. | ▲ Buy | Open Market | 2,400 | $33K | 6/12/2024 |
| Saba Capital Management, L.P. | ▲ Buy | Open Market | 2,039 | $28K | 6/11/2024 |
| Saba Capital Management, L.P. | ▲ Buy | Open Market | 9,704 | $133K | 6/10/2024 |
| Saba Capital Management, L.P. | ▲ Buy | Open Market | 3,763 | $52K | 6/7/2024 |
| Saba Capital Management, L.P. | ▲ Buy | Open Market | 9,598 | $132K | 6/6/2024 |
| Saba Capital Management, L.P. | ▲ Buy | Open Market | 26,083 | $359K | 6/5/2024 |
| Saba Capital Management, L.P. | ▲ Buy | Open Market | 33,357 | $450K | 6/4/2024 |
| Saba Capital Management, L.P. | ▲ Buy | Open Market | 21,369 | $284K | 5/31/2024 |
| Saba Capital Management, L.P. | ▲ Buy | Open Market | 669 | $9K | 5/30/2024 |
| Saba Capital Management, L.P. | ▲ Buy | Open Market | 38,033 | $498K | 5/29/2024 |
| Saba Capital Management, L.P. | ▲ Buy | Open Market | 8,714 | $117K | 5/28/2024 |
| Saba Capital Management, L.P. | ▲ Buy | Open Market | 1,303 | $18K | 5/23/2024 |
| Saba Capital Management, L.P. | ▲ Buy | Open Market | 34,755 | $493K | 5/15/2024 |
| Saba Capital Management, L.P. | ▲ Buy | Open Market | 57,862 | $802K | 5/10/2024 |
| Saba Capital Management, L.P. | ▲ Buy | Open Market | 17,373 | $240K | 5/9/2024 |
| Saba Capital Management, L.P. | ▲ Buy | Open Market | 10,986 | $151K | 5/8/2024 |
| Saba Capital Management, L.P. | ▲ Buy | Open Market | 50,161 | $690K | 5/7/2024 |
| Saba Capital Management, L.P. | ▲ Buy | Open Market | 10,713 | $146K | 5/6/2024 |
| Saba Capital Management, L.P. | ▲ Buy | Open Market | 26,274 | $354K | 5/2/2024 |
| Saba Capital Management, L.P. | ▲ Buy | Open Market | 252 | $3K | 5/1/2024 |
| Saba Capital Management, L.P. | ▲ Buy | Open Market | 16,573 | $218K | 4/30/2024 |
| Saba Capital Management, L.P. | ▲ Buy | Open Market | 120,304 | $1.6M | 4/26/2024 |
| Saba Capital Management, L.P. | ▲ Buy | Open Market | 97,574 | $1.3M | 4/25/2024 |
| Saba Capital Management, L.P. | ▲ Buy | Open Market | 20,529 | $269K | 4/24/2024 |
| Saba Capital Management, L.P. | ▲ Buy | Open Market | 48,203 | $634K | 4/23/2024 |
| Saba Capital Management, L.P. | ▲ Buy | Open Market | 2,022 | $26K | 4/22/2024 |
| Saba Capital Management, L.P. | ▲ Buy | Open Market | 42,459 | $545K | 4/19/2024 |
| Saba Capital Management, L.P. | ▲ Buy | Open Market | 81,738 | $1.0M | 4/18/2024 |
| Kathleen Goetz | ▲ Buy | Open Market | 400 | $5K | 4/9/2024 |
| Todd Reit | ▲ Buy | Open Market | 1,000 | $14K | 1/2/2024 |
| Bill Maher | ▲ Buy | Open Market | 1,000 | $14K | 12/28/2023 |
| Daniel R. Omstead | ▲ Buy | Open Market | 10,096 | $125K | 9/25/2023 |
| Daniel R. Omstead | ▲ Buy | Open Market | 12,000 | $152K | 9/20/2023 |
| Kathleen Goetz | ▲ Buy | Open Market | 92 | $2K | 3/23/2022 |
| Kathleen Goetz | ▲ Buy | Open Market | 593 | $10K | 1/26/2022 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 26, 2026
HQL Listed Among Top CEFs for September 2026 Yield
abrdn Life Sciences Investors (HQL) was included in a recent list of the ten best closed-end funds for September 2026, which highlights an average yield of 10%. This inclusion suggests the fund is being noted for its income potential within the broader CEF market. The stock is currently trading near its support level, reflecting a mixed technical picture alongside this fundamental recognition.
HQL Listed Among Top CEFs for September 2026 Yield. abrdn Life Sciences Investors (HQL) was included in a recent list of the ten best closed-end funds for September 2026, which highlights an average yield of 10%. This inclusion suggests the fund is being noted for its income potential within the broader CEF market. The stock is currently trading near its support level, reflecting a mixed technical picture alongside this fundamental recognition.